Markets & Investing
How Can I Get Involved in the Psychedelics Industry?: Mindshifting Moments #20
On this edition of Mindshifting Moments, Margaret Williamson is joined by Logan Lenz, the CEO of Nucleus. During this conversation, the two talk about…
On this edition of Mindshifting Moments, Margaret Williamson is joined by Logan Lenz, the CEO of Nucleus. During this conversation, the two talk about how the psychedelics industry is being built to be more accessible and overview the ways anyone can participate in the growing industry.
More About Nucleus
Nucleus was founded in mid-2021 after Neuly and Psychedelic Invest were purchased by Iter Investments, a prominent venture capital firm investing in the psychedelics industry. In late 2021, the official team was constructed, and Nucleus launched in January 2022 with the mission of connecting people with the psychedelics industry in order to propel psychedelic-assisted therapy forward. Nucleus strives to accomplish this mission by serving the industry as a venture studio building brands that educate the masses, activate new stakeholders, and distribute data about these powerful medicines.
Transcription
The transcription will be available after the event.
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Law & Regulation1 week ago
Tryp Therapeutics, Exopharm merger approved by shareholders
-
Psychedelics1 week ago
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
-
LSD1 week ago
The First Wave of Blotter Acid Inspired Trippy Psychedelic Art
-
Law & Regulation1 week ago
Adastra reports record sales in 2023, but remains in the red
-
Psilocybin7 days ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics5 days ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression